Orchestra BioMed Holdings, Inc. (OBIO)
NCM · Common · CUSIP 68572M106
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for OBIO and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
68572M106 (prev. G4411D109 )
Market Cap
Small Cap
IPO
8/7/2020 · $10.00/share
Previous Symbol
HSAQ (changed 1/27/2023)
Previous Name
Health Sciences Acquisitions Corp 2
Business: Orchestra BioMed Holdings, Inc. is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Orchestra BioMed’s flagship product candidates include BackBeat Cardiac Neuromodulation Therapy for the treatment of hypertension, a significant risk factor for death worldwide,and Sirolimus AngioInfusion™ Balloon for the treatment of atherosclerotic artery disease, the leading cause of mortality worldwide.

Company Contact

CEO
David P. Hochman
CFO
Andrew Taylor
Headquarters
150 Union Square Drive, New Hope, PA 18938
Phone
215-862-5797
Investor Relations
Bob Yedid, LifeSci Adbisors · 646-597-6989 · Bob@lifesciadvisors.com
SEC EDGAR Filings
View filings »